CompletedNot Applicable

The Effect of Valproate on Benzodiazepine Withdrawal Severity

Finland30 participantsStarted 2005-02

Plain-language summary

The aim of this study is to determine whether valproate is effective in the treatment of benzodiazepine withdrawal symptoms in subjects receiving maintenance treatment for opiate dependence.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of benzodiazepine dependence (DSM IV-R) * Induction of buprenorphine or methadon maintenance treatment, or need of benzodiazepine withdrawal treatment during ongoing buprenorphine/methadon maintenance Exclusion Criteria: * Pregnancy * History of convulsions * Unstable somatic diseases

What they're measuring

benzodiazepine withdrawal severity

Timeframe: 3 weeks

Trial details

NCT IDNCT00570219

SponsorUniversity of Helsinki

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2008-05

View on ClinicalTrials.gov More Substance Withdrawal Syndrome trials